Package 63323-825-20

{"route": ["INTRAVENOUS"], "spl_id": "d3d820f1-175e-4613-bdab-74c15f45912e", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["776B62CQ27"], "rxcui": ["636631"], "spl_set_id": ["4d568777-0946-489c-99bf-57e1f562e285"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63323-825-20)  / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-825-20", "marketing_start_date": "20191202"}], "brand_name": "Decitabine", "product_id": "63323-825_d3d820f1-175e-4613-bdab-74c15f45912e", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "63323-825", "generic_name": "Decitabine", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Decitabine", "active_ingredients": [{"name": "DECITABINE", "strength": "50 mg/20mL"}], "application_number": "ANDA210756", "marketing_category": "ANDA", "marketing_start_date": "20191202", "listing_expiration_date": "20261231"}